Tuesday, 4 June 2013

Dr. Morris on Radium-223 Plus Docetaxel in Patients With Bone Metastasis From CRPC

Can Far Infrared and Other Tools "Cancer-Proof" Your Body? Visit Healing Grapevine To Explore! Michael J. Morris, MD, discusses an ongoing phase I/IIa study looking at radium-223 with docetaxel in patients with bone metastasis from...

http://www.cancerfactorfiction.com/prostate-cancer-cures/dr-morris-on-radium-223-plus-docetaxel-in-patients-with-bone-metastasis-from-crpc/

No comments:

Post a Comment